Search
for
Sort by
Research 121–150 of 1000+
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- BIOLOGICAL ACTIVITY OF ANTIANDROGENS
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Intraoperative floppy-iris syndrome and finasteride intake
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II
- Clinical application of 5α-reductase inhibitors
- 5α-Reductases In Human Physiology: an Unfolding Story
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Finasteride
- Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite
- Antiandrogens: Clinical applications
- 5-Alpha reductase deficiency
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- Finasteride-its impact on sexual function and prostate cancer
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Baldness, benign prostate hyperplasia, prostate cancer and androgen levels